Coverage policy updates

Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.

Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.

Recorded changes

86,510 on record

Recorded policy changes, newest first
Recorded	Payer	Policy	Change
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: Mitochondrial DisordersPayerPolicy · ARKBLUE-GENETIC-TEST-MITOCHONDRIAL-DISORDERS	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: Microarray-Based Gene Expression Testing for Cancers of Unknown PrimaryPayerPolicy · ARKBLUE-GENETIC-TEST-MICROARRAY-BASED-GENE-EXPRESSION-TESTING-FOR-CANCERS-OF-UNKNOWN-PRIMARY	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: Melanoma, HereditaryPayerPolicy · ARKBLUE-GENETIC-TEST-MELANOMA-HEREDITARY	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: Melanoma and Glioma, Testing to Predict Response to Targeted TherapyPayerPolicy · ARKBLUE-GENETIC-TEST-MELANOMA-AND-GLIOMA-TESTING-TO-PREDICT-RESPONSE-TO-TARGETED-THERAPY	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: Macular DegenerationPayerPolicy · ARKBLUE-GENETIC-TEST-MACULAR-DEGENERATION	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: Lynch Syndrome and Inherited Intestinal Polyposis SyndromesPayerPolicy · ARKBLUE-GENETIC-TEST-LYNCH-SYNDROME-AND-INHERITED-INTESTINAL-POLYPOSIS-SYNDROMES	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: Limb-Girdle Muscular DystrophiesPayerPolicy · ARKBLUE-GENETIC-TEST-LIMB-GIRDLE-MUSCULAR-DYSTROPHIES	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: Li-Fraumeni SyndromePayerPolicy · ARKBLUE-GENETIC-TEST-LI-FRAUMENI-SYNDROME	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: Lactase InsufficiencyPayerPolicy · ARKBLUE-GENETIC-TEST-LACTASE-INSUFFICIENCY	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: KIT (c-KIT, CD117)PayerPolicy · ARKBLUE-GENETIC-TEST-KIT-C-KIT-CD117	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: JAK2, MPL, and CALR Testing for Myeloproliferative DisordersPayerPolicy · ARKBLUE-GENETIC-TEST-JAK2-MPL-AND-CALR-TESTING-FOR-MYELOPROLIFERATIVE-DISORDERS	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: Inherited Peripheral Neuropathies (Charcot Marie Tooth, HNPP)PayerPolicy · ARKBLUE-GENETIC-TEST-INHERITED-PERIPHERAL-NEUROPATHIES-CHARCOT-MARIE-TOOTH-HNPP	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: Hypertrophic Cardiomyopathy, PredispositionPayerPolicy · ARKBLUE-GENETIC-TEST-HYPERTROPHIC-CARDIOMYOPATHY-PREDISPOSITION	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: HLA-B*5701 Testing for Abacavir Hypersensitivity ReactionPayerPolicy · ARKBLUE-GENETIC-TEST-HLA-B-5701-TESTING-FOR-ABACAVIR-HYPERSENSITIVITY-REACTION	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: HFE HemochromatosisPayerPolicy · ARKBLUE-GENETIC-TEST-HFE-HEMOCHROMATOSIS	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: Hereditary PancreatitisPayerPolicy · ARKBLUE-GENETIC-TEST-HEREDITARY-PANCREATITIS	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: HER2 TestingPayerPolicy · ARKBLUE-GENETIC-TEST-HER2-TESTING	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: Head and Neck Cancer, EGFR Mutation Analysis to Predict Sensitivity to ChemotherapyPayerPolicy · ARKBLUE-GENETIC-TEST-HEAD-AND-NECK-CANCER-EGFR-MUTATION-ANALYSIS-TO-PREDICT-SENSITIVITY-TO-CHEMOTHERAPY	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: Germline Mutations of the RET Protooncogene in Medullary Carcinoma of the ThyroidPayerPolicy · ARKBLUE-GENETIC-TEST-GERMLINE-MUTATIONS-OF-THE-RET-PROTOONCOGENE-IN-MEDULLARY-CARCINOMA-OF-THE-THYROID	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: Gene Expression Profiling for Cutaneous MelanomaPayerPolicy · ARKBLUE-GENETIC-TEST-GENE-EXPRESSION-PROFILING-FOR-CUTANEOUS-MELANOMA	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: Genotyping for 9p21 Single Nucleotide Polymorphisms to Predict Risk of Cardiovascular Disease or AneurysmPayerPolicy · ARKBLUE-GENETIC-TEST-GENOTYPING-FOR-9P21-SINGLE-NUCLEOTIDE-POLYMORPHISMS-TO-PREDICT-RISK-OF-CARDIOVASCULAR-DISEASE-OR-ANEURYSM	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: Genotype-Guided Warfarin DosingPayerPolicy · ARKBLUE-GENETIC-TEST-GENOTYPE-GUIDED-WARFARIN-DOSING	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: Microarray-based Gene Expression Profile Analysis and Multimodal Artificial Intelligence for Prostate Cancer ManagementPayerPolicy · ARKBLUE-GENETIC-TEST-MICROARRAY-BASED-GENE-EXPRESSION-PROFILE-ANALYSIS-AND-MULTIMODAL-ARTIFICIAL-INTELLIGENCE-FOR-PROSTATE-CANCER-MANAGEMENT	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: Genetic Testing for Evaluation of Patients with Developmental Delay/Intellectual Disability or AutismPayerPolicy · ARKBLUE-GENETIC-TEST-GENETIC-TESTING-FOR-EVALUATION-OF-PATIENTS-WITH-DEVELOPMENTAL-DELAY-INTELLECTUAL-DISABILITY-OR-AUTISM	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: FMR 1 Mutations Including Fragile X SyndromePayerPolicy · ARKBLUE-GENETIC-TEST-FMR-1-MUTATIONS-INCLUDING-FRAGILE-X-SYNDROME	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: FLT, NPM1, and CEBPA Variants in Cytogenetically Normal Acute Myeloid LeukemiaPayerPolicy · ARKBLUE-GENETIC-TEST-FLT-NPM1-AND-CEBPA-VARIANTS-IN-CYTOGENETICALLY-NORMAL-ACUTE-MYELOID-LEUKEMIA	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: Fetal RHD Genotyping Using Maternal PlasmaPayerPolicy · ARKBLUE-GENETIC-TEST-FETAL-RHD-GENOTYPING-USING-MATERNAL-PLASMA	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: Fecal and Serologic Genetic Testing to Detect Colorectal Cancer, ScreeningPayerPolicy · ARKBLUE-GENETIC-TEST-FECAL-AND-SEROLOGIC-GENETIC-TESTING-TO-DETECT-COLORECTAL-CANCER-SCREENING	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: Fanconi AnemiaPayerPolicy · ARKBLUE-GENETIC-TEST-FANCONI-ANEMIA	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: Facioscapulohumeral Muscular DystrophyPayerPolicy · ARKBLUE-GENETIC-TEST-FACIOSCAPULOHUMERAL-MUSCULAR-DYSTROPHY	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: EpilepsyPayerPolicy · ARKBLUE-GENETIC-TEST-EPILEPSY	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: Duchenne and Becker Muscular DystrophyPayerPolicy · ARKBLUE-GENETIC-TEST-DUCHENNE-AND-BECKER-MUSCULAR-DYSTROPHY	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: Dilated CardiomyopathyPayerPolicy · ARKBLUE-GENETIC-TEST-DILATED-CARDIOMYOPATHY	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: Genetic and Protein Biomarkers for the Diagnosis and Cancer Risk Assessment of Prostate CancerPayerPolicy · ARKBLUE-GENETIC-TEST-GENETIC-AND-PROTEIN-BIOMARKERS-FOR-THE-DIAGNOSIS-AND-CANCER-RISK-ASSESSMENT-OF-PROSTATE-CANCER	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: Cytochrome p450 Genotype Guided Treatment StrategyPayerPolicy · ARKBLUE-GENETIC-TEST-CYTOCHROME-P450-GENOTYPE-GUIDED-TREATMENT-STRATEGY	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: Colon Cancer, Gene Expression Profiling (Oncotype DX, Colon PRS, Onco Defender-CRC, ColoPrint)PayerPolicy · ARKBLUE-GENETIC-TEST-COLON-CANCER-GENE-EXPRESSION-PROFILING-ONCOTYPE-DX-COLON-PRS-ONCO-DEFENDER-CRC-COLOPRINT	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: Chronic Myelogenous Leukemia and Acute Lymphoblastic Leukemia (BCR-ABL)PayerPolicy · ARKBLUE-GENETIC-TEST-CHRONIC-MYELOGENOUS-LEUKEMIA-AND-ACUTE-LYMPHOBLASTIC-LEUKEMIA-BCR-ABL	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: Chromosomal Microarray Testing for the Evaluation of Pregnancy LossPayerPolicy · ARKBLUE-GENETIC-TEST-CHROMOSOMAL-MICROARRAY-TESTING-FOR-THE-EVALUATION-OF-PREGNANCY-LOSS	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: CHARGE SyndromePayerPolicy · ARKBLUE-GENETIC-TEST-CHARGE-SYNDROME	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts & Leukoencephalopathy (CADASIL) (NOTCH3)PayerPolicy · ARKBLUE-GENETIC-TEST-CEREBRAL-AUTOSOMAL-DOMINANT-ARTERIOPATHY-WITH-SUBCORTICAL-INFARCTS-LEUKOENCEPHALOPATHY-CADASIL-NOTCH3	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: Celiac Disease, HLA Typing (HLA-DQ)PayerPolicy · ARKBLUE-GENETIC-TEST-CELIAC-DISEASE-HLA-TYPING-HLA-DQ	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: Cardiac Ion Channelopathies (Long QT Syndrome, Brugada Syndrome, CPVT, Short QT Syndrome)PayerPolicy · ARKBLUE-GENETIC-TEST-CARDIAC-ION-CHANNELOPATHIES-LONG-QT-SYNDROME-BRUGADA-SYNDROME-CPVT-SHORT-QT-SYNDROME	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: Carbamazepine HLA-B*1502PayerPolicy · ARKBLUE-GENETIC-TEST-CARBAMAZEPINE-HLA-B-1502	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: Canavan DiseasePayerPolicy · ARKBLUE-GENETIC-TEST-CANAVAN-DISEASE	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: Germline Testing for Gene Variants Associated with Breast Cancer in Individuals at High Breast Cancer Risk (CHEK2, ATM and BARD1)PayerPolicy · ARKBLUE-GENETIC-TEST-GERMLINE-TESTING-FOR-GENE-VARIANTS-ASSOCIATED-WITH-BREAST-CANCER-IN-INDIVIDUALS-AT-HIGH-BREAST-CANCER-RISK-CHEK2-ATM-AND-BARD1	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: BRCA1, BRCA2 or PALB2 MutationsPayerPolicy · ARKBLUE-GENETIC-TEST-BRCA1-BRCA2-OR-PALB2-MUTATIONS	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: Beckwith-Wiedemann SyndromePayerPolicy · ARKBLUE-GENETIC-TEST-BECKWITH-WIEDEMANN-SYNDROME	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: Asthma, HLA-DR and HLA-DQ GenotypingPayerPolicy · ARKBLUE-GENETIC-TEST-ASTHMA-HLA-DR-AND-HLA-DQ-GENOTYPING	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: Assays of Genetic Expression in Tumor Tissue to Determine Prognosis in Patients With Breast Cancer (Oncotype DX, EndoPredict, Breast Cancer Index, Prosigna, Mammaprint)PayerPolicy · ARKBLUE-GENETIC-TEST-ASSAYS-OF-GENETIC-EXPRESSION-IN-TUMOR-TISSUE-TO-DETERMINE-PROGNOSIS-IN-PATIENTS-WITH-BREAST-CANCER-ONCOTYPE-DX-ENDOPREDICT-BREAST-CANCER-INDEX-PROS	New policy
Aug 2, 2026	Arkansas Blue Cross and Blue Shield	Genetic Test: Amyotrophic Lateral SclerosisPayerPolicy · ARKBLUE-GENETIC-TEST-AMYOTROPHIC-LATERAL-SCLEROSIS	New policy